Abstract
A major limitation with traditional phage preparations is the variability in titer, salts, and bacterial contaminants between successive propagations. Here we introduce the Phage On Tap (PoT) protocol for the quick and efficient preparation of homogenous bacteriophage (phage) stocks. This method produces homogenous, laboratory-scale, high titer (up to 1010–11 PFU·ml−1), endotoxin reduced phage banks that can be used to eliminate the variability between phage propagations and improve the molecular characterizations of phage. The method consists of five major parts, including phage propagation, phage clean up by 0.22 μm filtering and chloroform treatment, phage concentration by ultrafiltration, endotoxin removal, and the preparation and storage of phage banks for continuous laboratory use. From a starting liquid lysate of > 100 mL, the PoT protocol generated a clean, homogenous, laboratory phage bank with a phage recovery efficiency of 85% within just two days. In contrast, the traditional method took upwards of five days to produce a high titer, but lower volume phage stock with a recovery efficiency of only 4%. Phage banks can be further purified for the removal of bacterial endotoxins, reducing endotoxin concentrations by over 3,000-fold while maintaining phage titer. The PoT protocol focused on T-like phages, but is broadly applicable to a variety of phages that can be propagated to sufficient titer, producing homogenous, high titer phage banks that are applicable for molecular and cellular assays.
Highlights
Due to increasing interest for the use of bacteriophage in medical, industrial, and molecular settings, new approaches are required to quickly and efficiently produce high titer, homogenous, and purified phage stocks
From our experience the use of homogenous and standardized phage banks can significantly reduce the experimental variability for the molecular characterization of phages
The Phage On Tap (PoT) protocol consisted of phage clean up, concentration and washing via ultrafiltration and resulted in a 93% reduction in volume with a phage recovery efficiency of 85%, while taking just two days to complete
Summary
Due to increasing interest for the use of bacteriophage (phage) in medical, industrial, and molecular settings, new approaches are required to quickly and efficiently produce high titer, homogenous, and purified phage stocks. Many of these techniques are time consuming and affect phage recovery and/or viability
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.